+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Gefitinib API Global Market

Gefitinib API Global Market

Global Gefitinib API Market Industry Research Report 2026

Explore detailed insights, trends, growth drivers, key players, and forecasts for the Global Gefitinib API Market Industry Research Report 2026 market worldwide.

Pages: 210

Format: PDF

Date: 01-2026

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Gefitinib API Market Report (2026–2036)

Market Overview

Chem Reports projects that the Gefitinib API Market, valued at USD xxxx units in 2025, is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% globally.

The Global Gefitinib API Market Report 2025 provides an extensive industry analysis of development drivers, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2026–2036. This research integrates both primary and secondary data sources, examining government policies, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic has spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the Gefitinib API market in 2020, disrupting supply chains, altering demand patterns, and reshaping investment priorities across oncology and pharmaceutical manufacturing sectors.

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Gefitinib Tablets
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Gefitinib API market include:

  • Scion Pharm Taiwan
  • Nischem International
  • Jeil Pharmaceutical
  • Farmhispania Group
  • Brawn Laboratories
  • Chem Genix
  • Qilu Pharmaceutical
  • Cipla
  • Zhuhai Rundu Pharma
  • Zhejiang Hisun Pharmaceutical

Global Gefitinib API Market Intelligence Brief (2026–2036)

Short Description / Definition

Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in oncology, primarily for the treatment of non-small cell lung cancer (NSCLC). As an active pharmaceutical ingredient (API), it is critical for oral formulations such as tablets. The market is shaped by oncology demand, regulatory compliance, and pharmaceutical innovation.

Regional Analysis

  • North America: Strong demand in oncology APIs, with the U.S. leading due to advanced pharmaceutical R&D and FDA oversight.
  • Europe: Growth driven by oncology drug development and generics. Germany, France, and the U.K. are key hubs, supported by EMA regulations.
  • Asia-Pacific: Fastest-growing region, led by China, India, and Japan. Expansion fueled by generic manufacturing, oncology prevalence, and government healthcare initiatives.
  • South America: Moderate growth, with Brazil showing demand in oncology APIs and generics.
  • Middle East & Africa: Emerging adoption in oncology treatments, though market penetration remains limited compared to other regions.

Porter’s Five Forces

  1. Competitive Rivalry: High; global players (Cipla, Qilu Pharmaceutical, Zhejiang Hisun) compete with regional manufacturers.
  2. Threat of New Entrants: Moderate; entry barriers include regulatory approvals, GMP compliance, and capital-intensive production.
  3. Bargaining Power of Suppliers: Moderate; raw material suppliers hold leverage due to limited sources of intermediates.
  4. Bargaining Power of Buyers: High; pharmaceutical companies and hospitals demand cost-effective, compliant APIs.
  5. Threat of Substitutes: Moderate; alternative oncology APIs exist but Gefitinib remains relevant due to its efficacy in NSCLC.

SWOT Analysis

Strengths

  • Established use in NSCLC treatments.
  • Wide applicability in oral formulations.
  • Strong demand in targeted cancer therapeutics.

Weaknesses

  • High production and compliance costs.
  • Regulatory complexity across regions.

Opportunities

  • Rising cancer prevalence globally.
  • Growth in Asia-Pacific generic manufacturing.
  • Development of combination therapies with Gefitinib.

Threats

  • Raw material price volatility.
  • Stringent regulatory hurdles.
  • Competition from alternative oncology APIs (e.g., Erlotinib, Osimertinib).

Trend Analysis

  • Increasing use in oncology APIs for targeted chemotherapy regimens.
  • Rising demand in generic formulations across Asia-Pacific.
  • Growth in combination therapies for enhanced efficacy.
  • Expansion of pharmaceutical R&D in targeted oncology.

Drivers & Challenges

Drivers

  • Expanding oncology drug market.
  • Rising prevalence of lung cancer worldwide.
  • Technological advancements in API manufacturing.

Challenges

  • High R&D and compliance costs.
  • Regulatory restrictions on oncology APIs.
  • Supply chain disruptions for raw materials.

Value Chain Analysis

  • Raw Materials: Specialty intermediates, solvents.
  • Manufacturing: API synthesis, purification, GMP compliance.
  • Distribution: Global distributors, pharmaceutical partnerships.
  • End-Use Industries: Oncology pharmaceuticals, hospitals, research institutions.
  • Regulatory Bodies: FDA, EMA, WHO shaping compliance requirements.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in R&D for combination therapies and cost-efficient production methods.
  • Investors: Focus on Asia-Pacific generic oncology markets where growth potential is strongest.
  • Regulators: Support harmonized global standards for oncology APIs.
  • Pharma Companies: Collaborate with API suppliers to ensure compliance and cost efficiency.
  • Distributors: Expand presence in emerging markets with campaigns highlighting therapeutic relevance.

Explore more reports here-

https://chemreports.com/reports

 

 

1. Market Overview of Gefitinib API
    1.1 Gefitinib API Market Overview
        1.1.1 Gefitinib API Product Scope
        1.1.2 Market Status and Outlook
    1.2 Gefitinib API Market Size by Regions:
    1.3 Gefitinib API Historic Market Size by Regions
    1.4 Gefitinib API Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2025 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Gefitinib API Sales Market by Type
    2.1 Global Gefitinib API Historic Market Size by Type
    2.2 Global Gefitinib API Forecasted Market Size by Type
    2.3 Purity ? 98 %
    2.4 Purity ? 99 %
3. Covid-19 Impact Gefitinib API Sales Market by Application
    3.1 Global Gefitinib API Historic Market Size by Application
    3.2 Global Gefitinib API Forecasted Market Size by Application
    3.3 Gefitinib Tablets
    3.4 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Gefitinib API Production Capacity Market Share by Manufacturers
    4.2 Global Gefitinib API Revenue Market Share by Manufacturers
    4.3 Global Gefitinib API Average Price by Manufacturers
5. Company Profiles and Key Figures in Gefitinib API Business
    5.1 Scion Pharm Taiwan
        5.1.1 Scion Pharm Taiwan Company Profile
        5.1.2 Scion Pharm Taiwan Gefitinib API Product Specification
        5.1.3 Scion Pharm Taiwan Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.2 Nischem International
        5.2.1 Nischem International Company Profile
        5.2.2 Nischem International Gefitinib API Product Specification
        5.2.3 Nischem International Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.3 Jeil Pharmaceutical
        5.3.1 Jeil Pharmaceutical Company Profile
        5.3.2 Jeil Pharmaceutical Gefitinib API Product Specification
        5.3.3 Jeil Pharmaceutical Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.4 Farmhispania Group
        5.4.1 Farmhispania Group Company Profile
        5.4.2 Farmhispania Group Gefitinib API Product Specification
        5.4.3 Farmhispania Group Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.5 Brawn Laboratories
        5.5.1 Brawn Laboratories Company Profile
        5.5.2 Brawn Laboratories Gefitinib API Product Specification
        5.5.3 Brawn Laboratories Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.6 Chem Genix
        5.6.1 Chem Genix Company Profile
        5.6.2 Chem Genix Gefitinib API Product Specification
        5.6.3 Chem Genix Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.7 Qilu Pharmaceutial
        5.7.1 Qilu Pharmaceutial Company Profile
        5.7.2 Qilu Pharmaceutial Gefitinib API Product Specification
        5.7.3 Qilu Pharmaceutial Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.8 Cipla
        5.8.1 Cipla Company Profile
        5.8.2 Cipla Gefitinib API Product Specification
        5.8.3 Cipla Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.9 Zhuhai Rundu Pharma
        5.9.1 Zhuhai Rundu Pharma Company Profile
        5.9.2 Zhuhai Rundu Pharma Gefitinib API Product Specification
        5.9.3 Zhuhai Rundu Pharma Gefitinib API Production Capacity, Revenue, Price and Gross Margin
    5.10 Zhejiang Hisun Pharmaceutical
        5.10.1 Zhejiang Hisun Pharmaceutical Company Profile
        5.10.2 Zhejiang Hisun Pharmaceutical Gefitinib API Product Specification
        5.10.3 Zhejiang Hisun Pharmaceutical Gefitinib API Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Gefitinib API Market Size
    6.2 North America Gefitinib API Key Players in North America
    6.3 North America Gefitinib API Market Size by Type
    6.4 North America Gefitinib API Market Size by Application
7. East Asia
    7.1 East Asia Gefitinib API Market Size
    7.2 East Asia Gefitinib API Key Players in North America
    7.3 East Asia Gefitinib API Market Size by Type
    7.4 East Asia Gefitinib API Market Size by Application
8. Europe
    8.1 Europe Gefitinib API Market Size
    8.2 Europe Gefitinib API Key Players in North America
    8.3 Europe Gefitinib API Market Size by Type
    8.4 Europe Gefitinib API Market Size by Application
9. South Asia
    9.1 South Asia Gefitinib API Market Size
    9.2 South Asia Gefitinib API Key Players in North America
    9.3 South Asia Gefitinib API Market Size by Type
    9.4 South Asia Gefitinib API Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Gefitinib API Market Size
    10.2 Southeast Asia Gefitinib API Key Players in North America
    10.3 Southeast Asia Gefitinib API Market Size by Type
    10.4 Southeast Asia Gefitinib API Market Size by Application
11. Middle East
    11.1 Middle East Gefitinib API Market Size
    11.2 Middle East Gefitinib API Key Players in North America
    11.3 Middle East Gefitinib API Market Size by Type
    11.4 Middle East Gefitinib API Market Size by Application
12. Africa
    12.1 Africa Gefitinib API Market Size
    12.2 Africa Gefitinib API Key Players in North America
    12.3 Africa Gefitinib API Market Size by Type
    12.4 Africa Gefitinib API Market Size by Application
13. Oceania
    13.1 Oceania Gefitinib API Market Size
    13.2 Oceania Gefitinib API Key Players in North America
    13.3 Oceania Gefitinib API Market Size by Type
    13.4 Oceania Gefitinib API Market Size by Application
14. South America
    14.1 South America Gefitinib API Market Size
    14.2 South America Gefitinib API Key Players in North America
    14.3 South America Gefitinib API Market Size by Type
    14.4 South America Gefitinib API Market Size by Application
15. Rest of the World
    15.1 Rest of the World Gefitinib API Market Size
    15.2 Rest of the World Gefitinib API Key Players in North America
    15.3 Rest of the World Gefitinib API Market Size by Type
    15.4 Rest of the World Gefitinib API Market Size by Application
16 Gefitinib API Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Gefitinib Tablets
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Gefitinib API market include:

  • Scion Pharm Taiwan
  • Nischem International
  • Jeil Pharmaceutical
  • Farmhispania Group
  • Brawn Laboratories
  • Chem Genix
  • Qilu Pharmaceutical
  • Cipla
  • Zhuhai Rundu Pharma
  • Zhejiang Hisun Pharmaceutical

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.